Jerome Ritz

Jerome Ritz, MD, is Professor of Medicine at Harvard Medical School and a leading specialist in graft versus leukemia (GVL), graft versus host disease (GVHD). bone marrow transplantation, immuno-oncology and cell manufacturing. Dr. Ritz's research lab at the Dana- Farber Cancer Institute has revealed mechanisms of GVL and demonstrated the key role of Treg in chronic GVHD after hematopoietic stem celltransplantation. Dr. Ritz is also the Executive Director of the Cell Manipulation Core Facility at the Dana-Farber Cancer Institute. This academic GMP cell manufacturing facility provides a variety of cellular products including CAR T-cells, NK cells, genetically modified hematopoietic stem cells and regulatory T-cells for adult and pediatric patients enrolled on early phase clinical trials.